Yuichiro Watanabe, Masataka Otake, Shin Ono, Masaya Ootake, Kazuhiro Murakami, Koichiro Kumagai, Koji Matsuzawa, Hiroyuki Kasahara, Kazuhiro Hori, Toshiyuki Someya. Decreased oral function in Japanese inpatients with schizophrenia. Neuropsychopharmacology Reports. 2024
Yuichiro Watanabe, Shin Ono, Takuro Sugai, Yutaro Suzuki, Manabu Yamazaki, Norio Sugawara, Norio Yasui-Furukori, Kazutaka Shimoda, Takao Mori, Yuji Ozeki, et al. Associations between the number of antipsychotics prescribed and metabolic parameters in Japanese patients with schizophrenia. Psychiatry and Clinical Neurosciences Reports. 2022. 1. 3
Masataka Otake, Shin Ono, Yuichiro Watanabe, Koichiro Kumagai, Koji Matsuzawa, Hiroyuki Kasahara, Masaya Ootake, Takuro Sugai, Toshiyuki Someya. Association Between the Number of Remaining Teeth and Body Mass Index in Japanese Inpatients with Schizophrenia. Neuropsychiatric disease and treatment. 2022. 18. 2591-2597
Atsunori Sugimoto, Yutaro Suzuki, Kiyohiro Yoshinaga, Naoki Orime, Taketsugu Hayashi, Jun Egawa, Shin Ono, Takuro Sugai, Toshiyuki Someya. Influence of Atomoxetine on Relationship Between ADHD Symptoms and Prefrontal Cortex Activity During Task Execution in Adult Patients. Frontiers in Human Neuroscience. 2021. 15
Atsunori Sugimoto, Yutaro Suzuki, Naoki Orime, Taketsugu Hayashi, Kiyohiro Yoshinaga, Jun Egawa, Shin Ono, Takuro Sugai, Yoshimasa Inoue, Toshiyuki Someya. The lowest effective plasma concentration of atomoxetine in pediatric patients with attention deficit/hyperactivity disorder. Medicine. 2021. 100. 27. e26552-e26552
